Elicio Therapeutics, Inc. (ELTX)
10.59
-0.18
(-1.67%)
USD |
NASDAQ |
May 05, 16:00
10.38
-0.21
(-1.98%)
After-Hours: 20:00
Elicio Therapeutics Total Liabilities (Quarterly) : 24.23M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aura Biosciences, Inc. | 183.06M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Savara, Inc. | 50.30M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.86M |
| Shareholders Equity (Quarterly) | 1.636M |
| Debt to Equity Ratio | 8.870 |
| Current Ratio | 2.381 |
| Net Debt Paydown Yield | 1.63% |